Module 5: New Medications in Movement Disorders

Shu-Ching Hu, MD, PhD
Movement Disorder Neurologist, Associate Professor of Neurology, University of Washington, Seattle

OBJECTIVES FOR LEARNING OUTCOMES

At the conclusion of this activity, participants will be better able to:

  1. Gain knowledge on the updates of Tardive Dyskinesia and its treatment.
  2. Describe new medications for Parkinson’s Disease.
  3. Describe new medications for non-motor symptoms of Parkinson’s Disease.

Presentation & Handout

Handout

New Mediations in Movement Disorders

Video